The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.

According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...

A recent paper reveals increasing rates of diabetic retinopathy in young patients with diabetes, sparking concerns over ...

Tinlarebant is an oral therapy designed to reduce the accumulation of vitamin A based toxins that cause retinal disease.

According to the company, the platform accompanies the launch of Qdata Retinitis Pigmentosa for life sciences and the ...

According to the company, a $68 million Series D financing is co-led by Arboretum Ventures and Johnson & Johnson Innovation – ...

β-amyloid deposits were found in the ocular glymphatic system of Alzheimer's patients and 5×FAD mice, indicating a ...

On World Sight Day, leading experts in ophthalmology look at artificial intelligence and how it could impact diagnosing and ...

Artificial intelligence has the potential to improve ophthalmology practices by streamlining documentation, enhancing ...

Ten of the institute's ophthalmologists will present their work in more than 20 sessions with a wide range of topics ...

The phase 3 clinical trial is a randomized, double-blind, three-arm study comparing MELT-300, sublingual midazolam, and ...

A team of researchers at Arizona State University has developed tools to aid in the diagnosis of myopic maculopathy.